TWM
EW icon

Tripletail Wealth Management’s Edwards Lifesciences EW Stock Holding History

Tripletail Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Sell
128
-396
-76% -$33.2K 0.01% 224
2026
Q1 		$42.5K Sell
524
-21
-4% -$1.73K 0.06% 155
2025
Q4 		$46.5K Sell
545
-36
-6% -$2.95K 0.06% 140
2025
Q3 		$45.1K Buy
+581
New +$45.4K 0.05% 166

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Tripletail Wealth Management's EW Position: Q2 2026 in Review

Tripletail Wealth Management reduced its Edwards Lifesciences (EW) stake by 76% in Q2 2026, selling an estimated $33.2K and leaving 128 shares worth $12.1K. The position accounts for 0.01% of the portfolio, ranked #224.

Tripletail Wealth Management first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $46.5K in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Tripletail Wealth Management held 128 shares of Edwards Lifesciences worth $12.1K as of Q2 2026.
  • Tripletail Wealth Management sold 396 Edwards Lifesciences shares in Q2 2026, an estimated $33.2K.
  • Edwards Lifesciences made up 0.01% of Tripletail Wealth Management's portfolio in Q2 2026, its #224 holding.
  • Tripletail Wealth Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • Tripletail Wealth Management's Edwards Lifesciences position peaked at $46.5K in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.